Alnylam Pharmaceuticals
ALNY
#759
Rank
$23.76 B
Marketcap
$190.83
Share price
0.21%
Change (1 day)
44.45%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Net assets

Net assets on the balance sheet as of December 2022 : -$0.16 B

According to Alnylam Pharmaceuticals 's latest financial reports the company has -$0.16 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Alnylam Pharmaceuticals - Net assets on balance sheet (from 2003 to 2022)

Net assets by year

Year Net assets Change
2022-12-31$-0.16 B-126.9%
2021-12-31$0.58 B-42.12%
2020-12-31$1.01 B-29.36%
2019-12-31$1.43 B10.5%
2018-12-31$1.30 B-26.29%
2017-12-31$1.76 B91.96%
2016-12-31$0.92 B-27.24%
2015-12-31$1.26 B35.08%
2014-12-31$0.93 B246.32%
2013-12-31$0.27 B101.67%
2012-12-31$0.13 B13.61%
2011-12-31$0.11 B-25.43%
2010-12-31$0.15 B-11.09%
2009-12-31$0.17 B-11.95%
2008-12-31$0.20 B1.48%
2007-12-31$0.19 B-1%
2006-12-31$0.20 B225.63%
2005-12-31$61.77 M33.89%
2004-12-31$46.14 M-272.77%
2003-12-31$-26.71 M474.84%
2002-12-31$-4.65 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
$52.14 B-33,054.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$80.48 B-50,968.58%๐Ÿ‡ซ๐Ÿ‡ท France
$22.66 B-14,424.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.71 B-550.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$33.29 M-121.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.55 B-1,080.77%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.69 B-5,592.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$0.46 B-393.96%๐Ÿ‡บ๐Ÿ‡ธ USA